Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Hologic Inc's Business Segments
Hologic Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
4
Largest Segment
Diagnostics
Total Revenue
$ 907
Regions Reported
4
Revenue Share by Reportable Segment - Q1 FY2026
- Diagnostics51.2%
- Breast Health41.4%
- GYN Surgical19.9%
- Skeletal Health2.9%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Diagnostics | $ 464 | 51.2% |
| Breast Health | $ 376 | 41.4% |
| GYN Surgical | $ 181 | 19.9% |
1 more segments available
Sign in to unlock the full Hologic Inc dataset.
Revenue Share by Region - Q1 FY2026
- Non-US30.2%
- Europe17.8%
- Asia Pacific6.2%
- Rest of World6.2%
Revenue by Geographic Region - Q1 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 274 | 30.2% |
| Europe | $ 162 | 17.8% |
| Asia Pacific | $ 57 | 6.2% |
1 more regions available
Sign in to unlock the full Hologic Inc dataset.
Revenue by Product & Service Category - Q1 FY2026
- Product91.6%
- Consumables71%
- Molecular Diagnostics36.3%
- Breast Imaging30.9%
- Service23.3%
- Capital Equipment, Components and Software20.6%
- Cytology & Perinatal14%
- Interventional Breast Solutions10.6%
- Blood Screening0.9%
- Other Type of Revenue0.6%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 831 | 91.6% |
| Consumables | $ 644 | 71% |
| Molecular Diagnostics | $ 329 | 36.3% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
7 more categories available
Sign in to unlock the full Hologic Inc dataset.
Description of Hologic Inc
Hologic, Inc. is a prominent U.S.-based medical technology company, founded in 1985, with its headquarters located in Marlborough, Massachusetts. The company specializes in comprehensive solutions aimed primarily at womens health, including diagnostic, surgical, and medical imaging equipment. Over the years, Hologic has expanded its service offerings and global reach, establishing operations in more than 50 countries.
The companys initial focus was on developing diagnostic products for osteoporosis, leveraging innovative technologies to meet the evolving needs of the healthcare market. Since its inception, Hologic has broadened its expertise to encompass a diverse array of medical technologies, particularly in the realms of cancer detection, gynecology, and skeletal health, as well as surgical products and accessories tailored for diagnostic imaging and breast biopsy procedures.
One of Hologics landmark achievements is the introduction of the Selenia Dimensions digital breast tomosynthesis (DBT) system, the first-ever 3D mammography technology, which received FDA approval in 2011. This pioneering system utilizes low-dose X-rays to create detailed, multi-layered images of the breast. It has significantly enhanced the early detection of breast cancer while reducing the overall incidence of follow-up biopsies—thereby sparking a revolution in breast cancer screening protocols.
Hologic continues to innovate in the field of diagnostics with advanced technologies such as the Panther Fusion system, which facilitates molecular diagnostic testing. Other notable products include NovaSure, a system for endometrial ablation designed to alleviate symptoms associated with heavy menstrual bleeding, and MyoSure, which is instrumental in the removal of uterine fibroids or polyps. Hologics commitment to womens health extends to providing services and products for prenatal testing, infertility treatment, and a variety of other gynecological and diagnostic needs.
Quality and patient outcomes are at the forefront of Hologics mission. The company prioritizes extensive research and development endeavors, consistently striving to introduce groundbreaking solutions that improve women’s health and redefine standards in diagnostics and medical imaging. They are dedicated to meeting the challenges of modern healthcare with innovative, reliable technologies that enhance patient care and operational efficiency.
Beyond advancing medical technology, Hologic is committed to sustainability and corporate responsibility. The organization actively seeks to reduce its environmental impact through sustainable practices, uphold ethical business standards, and foster a culture of diversity and inclusion within its workforce. This dedication not only enhances their corporate identity but also aligns with broader societal goals within the health sector and the communities they serve.
As a leader in the medical technology landscape, Hologic, Inc. plays a pivotal role in advancing healthcare solutions for women. Through their dedication to innovation, quality, patient health, and corporate responsibility, the company has established itself as a trusted partner in the medical community, continually working towards transforming the future of women’s healthcare.
The companys initial focus was on developing diagnostic products for osteoporosis, leveraging innovative technologies to meet the evolving needs of the healthcare market. Since its inception, Hologic has broadened its expertise to encompass a diverse array of medical technologies, particularly in the realms of cancer detection, gynecology, and skeletal health, as well as surgical products and accessories tailored for diagnostic imaging and breast biopsy procedures.
One of Hologics landmark achievements is the introduction of the Selenia Dimensions digital breast tomosynthesis (DBT) system, the first-ever 3D mammography technology, which received FDA approval in 2011. This pioneering system utilizes low-dose X-rays to create detailed, multi-layered images of the breast. It has significantly enhanced the early detection of breast cancer while reducing the overall incidence of follow-up biopsies—thereby sparking a revolution in breast cancer screening protocols.
Hologic continues to innovate in the field of diagnostics with advanced technologies such as the Panther Fusion system, which facilitates molecular diagnostic testing. Other notable products include NovaSure, a system for endometrial ablation designed to alleviate symptoms associated with heavy menstrual bleeding, and MyoSure, which is instrumental in the removal of uterine fibroids or polyps. Hologics commitment to womens health extends to providing services and products for prenatal testing, infertility treatment, and a variety of other gynecological and diagnostic needs.
Quality and patient outcomes are at the forefront of Hologics mission. The company prioritizes extensive research and development endeavors, consistently striving to introduce groundbreaking solutions that improve women’s health and redefine standards in diagnostics and medical imaging. They are dedicated to meeting the challenges of modern healthcare with innovative, reliable technologies that enhance patient care and operational efficiency.
Beyond advancing medical technology, Hologic is committed to sustainability and corporate responsibility. The organization actively seeks to reduce its environmental impact through sustainable practices, uphold ethical business standards, and foster a culture of diversity and inclusion within its workforce. This dedication not only enhances their corporate identity but also aligns with broader societal goals within the health sector and the communities they serve.
As a leader in the medical technology landscape, Hologic, Inc. plays a pivotal role in advancing healthcare solutions for women. Through their dedication to innovation, quality, patient health, and corporate responsibility, the company has established itself as a trusted partner in the medical community, continually working towards transforming the future of women’s healthcare.
Hologic Inc. is a prominent global leader in medical technology, primarily focusing on innovations in healthcare specifically tailored for women’s health. The company’s extensive portfolio is organized into several key segments, each offering a range of advanced products and services designed to meet critical healthcare needs. Below is a comprehensive overview of Hologics major segments and their offerings:
1. Breast Health
Hologics Breast Health segment is devoted to the diagnosis and treatment of breast cancer, featuring an array of sophisticated imaging and biopsy technologies aimed at enhancing screening and intervention efforts.
- Digital Mammography Systems: The flagship products include the Selenia, Selenia Dimensions, and 3D Mammography Systems. These systems utilize advanced imaging technologies to provide high-resolution images, allowing healthcare professionals to detect small anomalies in breast tissue. The incorporation of cutting-edge imaging algorithms enhances detection rates while minimizing false-positive results, leading to more accurate diagnoses.
- Biopsy Systems: The ATEC (Advanced Tissue Extraction System) and Eviva Biopsy Systems are designed for minimally invasive tissue sampling from breast lumps. These systems aim to improve patient comfort and boost procedural efficacy while ensuring accurate tissue sampling for diagnostic purposes.
- Breast Density Software: Hologic offers specialized software that assesses breast density, a critical factor linked to breast cancer risk. This tool supports clinicians in making informed decisions regarding screening protocols, particularly for women with dense breast tissue.
GYN Surgical
The GYN Surgical segment emphasizes innovations that enhance gynecological surgical procedures and patient outcomes for treating conditions such as uterine fibroids, cervical and endometrial cancers, and pelvic organ prolapse.
- MyoSure System: This minimally invasive system facilitates precise removal of abnormal tissue, such as fibroids, from the uterus. Utilizing real-time imaging guidance, MyoSure improves procedural accuracy and shortens recovery times for patients.
- NovaSure System: The NovaSure Endometrial Ablation System is designed to address heavy menstrual bleeding caused by uterine conditions. It provides a quick outpatient procedure that effectively ablates the endometrial lining, significantly improving quality of life for patients suffering from dysfunctional uterine bleeding.
Diagnostics
The Diagnostics segment includes a variety of solutions aimed at identifying and managing infectious diseases and conditions integral to women’s health.
- Panther System: This state-of-the-art automated diagnostic system offers rapid and reliable testing for a multitude of infectious diseases, including COVID-19, influenza, and various sexually transmitted infections (STIs). Its modular design allows healthcare facilities to scale their testing capabilities according to specific needs.
- Aptima STI Testing: With the Aptima testing platform, Hologic provides comprehensive screening and detection services for STIs, such as chlamydia, gonorrhea, and HPV. This platform equips healthcare professionals with essential tools for effective disease management and patient counseling.
Medical Aesthetics
The Medical Aesthetics segment offers products and technologies aimed at enhancing aesthetic outcomes through non-invasive procedures.
- SculpSure: The SculpSure device utilizes non-invasive laser technology to target and reduce stubborn fat deposits in problem areas, including the abdomen, back, and thighs. This treatment helps patients achieve a sculpted appearance without the need for surgical intervention.
- Icon Devices: The Icon platform encompasses a range of skin rejuvenation treatments tailored to reduce visible signs of aging, such as wrinkles and fine lines. The device employs multi-application technology, allowing for versatile treatment options depending on individual skin types and aesthetic concerns.
Skeletal Health
Hologic is committed to advancing understanding and treatment in skeletal health, focusing on diagnostic products that identify conditions such as osteoporosis.
- Dual-energy X-ray Absorptiometry (DXA) Systems: Hologic’s DXA systems are considered the gold standard for measuring bone mineral density (BMD). They play a crucial role in the early diagnosis of osteoporosis and assessment of fracture risks, providing accurate and reproducible measurements essential for effective patient management.
- Fluoroscan InSight FD Mini C-arm: This portable imaging solution is designed for diagnosing fractures and a variety of musculoskeletal conditions. The Fluoroscan InSight FD Mini C-arm offers real-time imaging capabilities that improve surgical planning and intraoperative decision-making.
Conclusion
In conclusion, Hologic Inc. presents a diverse and innovative array of products and services across multiple segments, all aimed at enhancing women’s health and delivering exceptional patient care. The company’s unwavering commitment to technological advancements ensures effective diagnosis, treatment, and management of a wide range of medical conditions. By fostering continuous innovation, Hologic maintains its position at the forefront of healthcare solutions, dedicated to improving the quality of life globally.
1. Breast Health
Hologics Breast Health segment is devoted to the diagnosis and treatment of breast cancer, featuring an array of sophisticated imaging and biopsy technologies aimed at enhancing screening and intervention efforts.
- Digital Mammography Systems: The flagship products include the Selenia, Selenia Dimensions, and 3D Mammography Systems. These systems utilize advanced imaging technologies to provide high-resolution images, allowing healthcare professionals to detect small anomalies in breast tissue. The incorporation of cutting-edge imaging algorithms enhances detection rates while minimizing false-positive results, leading to more accurate diagnoses.
- Biopsy Systems: The ATEC (Advanced Tissue Extraction System) and Eviva Biopsy Systems are designed for minimally invasive tissue sampling from breast lumps. These systems aim to improve patient comfort and boost procedural efficacy while ensuring accurate tissue sampling for diagnostic purposes.
- Breast Density Software: Hologic offers specialized software that assesses breast density, a critical factor linked to breast cancer risk. This tool supports clinicians in making informed decisions regarding screening protocols, particularly for women with dense breast tissue.
GYN Surgical
The GYN Surgical segment emphasizes innovations that enhance gynecological surgical procedures and patient outcomes for treating conditions such as uterine fibroids, cervical and endometrial cancers, and pelvic organ prolapse.
- MyoSure System: This minimally invasive system facilitates precise removal of abnormal tissue, such as fibroids, from the uterus. Utilizing real-time imaging guidance, MyoSure improves procedural accuracy and shortens recovery times for patients.
- NovaSure System: The NovaSure Endometrial Ablation System is designed to address heavy menstrual bleeding caused by uterine conditions. It provides a quick outpatient procedure that effectively ablates the endometrial lining, significantly improving quality of life for patients suffering from dysfunctional uterine bleeding.
Diagnostics
The Diagnostics segment includes a variety of solutions aimed at identifying and managing infectious diseases and conditions integral to women’s health.
- Panther System: This state-of-the-art automated diagnostic system offers rapid and reliable testing for a multitude of infectious diseases, including COVID-19, influenza, and various sexually transmitted infections (STIs). Its modular design allows healthcare facilities to scale their testing capabilities according to specific needs.
- Aptima STI Testing: With the Aptima testing platform, Hologic provides comprehensive screening and detection services for STIs, such as chlamydia, gonorrhea, and HPV. This platform equips healthcare professionals with essential tools for effective disease management and patient counseling.
Medical Aesthetics
The Medical Aesthetics segment offers products and technologies aimed at enhancing aesthetic outcomes through non-invasive procedures.
- SculpSure: The SculpSure device utilizes non-invasive laser technology to target and reduce stubborn fat deposits in problem areas, including the abdomen, back, and thighs. This treatment helps patients achieve a sculpted appearance without the need for surgical intervention.
- Icon Devices: The Icon platform encompasses a range of skin rejuvenation treatments tailored to reduce visible signs of aging, such as wrinkles and fine lines. The device employs multi-application technology, allowing for versatile treatment options depending on individual skin types and aesthetic concerns.
Skeletal Health
Hologic is committed to advancing understanding and treatment in skeletal health, focusing on diagnostic products that identify conditions such as osteoporosis.
- Dual-energy X-ray Absorptiometry (DXA) Systems: Hologic’s DXA systems are considered the gold standard for measuring bone mineral density (BMD). They play a crucial role in the early diagnosis of osteoporosis and assessment of fracture risks, providing accurate and reproducible measurements essential for effective patient management.
- Fluoroscan InSight FD Mini C-arm: This portable imaging solution is designed for diagnosing fractures and a variety of musculoskeletal conditions. The Fluoroscan InSight FD Mini C-arm offers real-time imaging capabilities that improve surgical planning and intraoperative decision-making.
Conclusion
In conclusion, Hologic Inc. presents a diverse and innovative array of products and services across multiple segments, all aimed at enhancing women’s health and delivering exceptional patient care. The company’s unwavering commitment to technological advancements ensures effective diagnosis, treatment, and management of a wide range of medical conditions. By fostering continuous innovation, Hologic maintains its position at the forefront of healthcare solutions, dedicated to improving the quality of life globally.